Skip to main content
Press Release

Cape Cod Dental Practice Settles Drug Diversion Allegations

For Immediate Release
U.S. Attorney's Office, District of Massachusetts

BOSTON – The U.S. Attorney’s Office reached a $25,000 civil settlement with Dr. Richard Bravman, Dr. John Langston, and their Cape Cod dental practice, Bravman, Langston, and Associates, LLC in connection with the practice’s flawed recordkeeping of controlled substances.

According to court documents, the practice allegedly failed to conduct required inventories of controlled substances, to keep inventories of drugs on hand, to maintain dispensing records and invoices for drug transfers between practice locations, and to create order forms for controlled substances.  The practice also allegedly failed to report a theft of a controlled substance to the DEA as it was required to do.

Upon learning of the violations at their practice, Drs. Bravman and Langston cooperated with the investigation.  In consultation with the DEA, they have implemented new recordkeeping procedures to ensure compliance with regulations aimed at avoiding diversion of controlled substances from medical offices.

Drs. Bravman and Langston agreed to pay $25,000 to settle these claims and to permit the DEA to perform administrative inspections of the practice’s offices during the next three years without a warrant.

United States Attorney Carmen M. Ortiz and Michael J. Ferguson, Special Agent in Charge of the Drug Enforcement Administration, New England Field Division, made the announcement today.  The case was handled by Assistant U.S. Attorney Kriss Basil of Ortiz’s Civil Division.

Updated February 25, 2016

Prescription Drugs